综合祛痰治疗在COPD缓解期患者家庭护理中的效果观察  

The effect of integrated expectorant treatment in home care in chronic obstructive pulmonary disease patients in remission

作　　者：许传芬[1] 

机构地区：[1]日照市人民医院内科,276800

出　　处：《国际护理学杂志》2015年第14期1903-1907,共5页international journal of nursing

摘　　要：目的探索综合祛痰治疗在COPD缓解期患者家庭护理中的疗效。方法120例于本院治疗的COPD患者,出院后被分为对照组及观察组,对照组给予沐舒坦片及复方鲜竹沥祛痰治疗,观察组给予盐酸氨溴索注射液超声雾化吸入加复方鲜竹沥祛痰治疗,一年后对两组进行评估。结果症状评估对照组mMRC分级0-1患者34例（57.0%）,观察组47例（78.3%）,观察组显著高于对照组,两组差异有统计学意义（P=0.01）；肺功能评估GOLD1-2对照组39例（65.0%）,观察组46例（77.7%）,两组无统计学差异（P=0.16）；每年急性加重次数评估≤1次对照组15例（25.0%）,观察组28例（46.7%）,两组有统计学差异（ P=0.01）,观察组高于对照组；并发症评估,两组家庭治疗一年内均无死亡患者,观察组在代谢综合征、焦虑和抑郁发生率明显低于对照组,两组有统计学差异（P=0.02,P=0.03）；综合评估,对照组A组11例（18.3%）,观察组21例（35.0%）,两组有统计学差异（ P=0.04）,对照组显著低于观察组。对照组D组25例（46.7%）,观察组11例（18.3%）,两组有统计学差异（P=0.01）,对照组显著高于观察组。结论采用盐酸氨溴索超声雾化吸入联合口服复方鲜竹沥化痰治疗在COPD稳定期康复治疗中起着重要的作用,可推广使用。Objective To explore the effect of integrated expectorant treatment in home care in chronic obstructive pulmonary disease （ COPD） patients in remission. Methods 120 cases of COPD patients in the hospital were divided into the observation group and control group discharged from hospital. Patients in the control group were given the Mucosolvan sheets and the compound Xianzhuli expectorant treatment, in the observation group were treated with ultrasonic atomizing inhalation of ambroxol hydrochloride injection plusthe compound Xianzhuli expectorant treatment. 1 year later, patients in the two groups were evaluated. Results Symptoms assessment：there were 34 （57. 0%） cases in control group and 47 （78. 3%） cases in observation group of mMRC grade 0-1, rate of control group was higher than that of observation group, there was significant difference between two groups （P=0. 01）. Lung function assessment：there were 39 cases （65. 0%） in control group and 46 cases （77. 7%） in the observation group of GOLD1 - 2, there was no significant difference between the control group and observation group （ P=0. 16 ） . There were 15 cases （25. 0%） in the control group and 28 cases （46. 7%） in the observation of the number of assessment each year with acute exacerbation≤1 , there was significant difference （ P=0. 01 ） and the rate of the observed group was higher than that of the control group. Complications assessment：there was no dead patient in the two groups within 1 year. The incidence of metabolic syndrome, anxiety and depression in the observation group were significantly lower than those of control group （ P=0. 02 , P=0. 03 ） . Comprehensive assessment： there were 11 cases （ 18. 3%） in control group and 21 cases （35. 0%） in observation group in group A （P=0. 04）, the rate of the control group was significantly lower than that of the observation group. there were 25 cases （ 18. 3%） in control group and 11 cases （ 35. 0%） in observation group in group D （ P

关 键 词：慢性阻塞性肺疾病 超声雾化吸入 缓解期 

分 类 号：R473.2[医药卫生—护理学]